Shoug M Alashmali1, Kathryn E Hopperton, Richard P Bazinet. 1. Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada *Shoug M. Alashmali and Kathryn E. Hopperton contributed equally to the writing of this article.
Abstract
PURPOSE OF REVIEW: Arachidonic (ARA) and docosahexaenoic (DHA) acids are the most abundant polyunsaturated fatty acids (PUFA) in the brain, where they have many biological effects, including on inflammation, cell-signaling, appetite regulation, and blood flow. The Western diet contains a high ratio of n-6: n-3 PUFA. Although interest in lowering this ratio has largely focused on increasing intake of n-3 PUFA, few studies have examined lowering dietary n-6 PUFA. This review will evaluate the effect of lowering dietary n-6 PUFA on levels and metabolism of ARA and DHA in animal models and in humans, with a primary focus on the brain. RECENT FINDINGS: In animal models, lowering dietary ARA or linoleic acid generally lowers levels of brain ARA and raises DHA. Lowering dietary n-6 PUFA can also modulate the levels of ARA and DHA metabolizing enzymes, as well as their associated bioactive mediators. Human studies examining changes in plasma fatty acid composition following n-6 PUFA lowering demonstrate no changes in levels of ARA and DHA, though there is evidence of alterations in their respective bioactive mediators. SUMMARY: Lowering dietary n-6 PUFA, in animal models, can alter the levels and metabolism of ARA and DHA in the brain, but it remains to be determined whether these changes are clinically meaningful.
PURPOSE OF REVIEW: Arachidonic (ARA) and docosahexaenoic (DHA) acids are the most abundant polyunsaturated fatty acids (PUFA) in the brain, where they have many biological effects, including on inflammation, cell-signaling, appetite regulation, and blood flow. The Western diet contains a high ratio of n-6: n-3 PUFA. Although interest in lowering this ratio has largely focused on increasing intake of n-3 PUFA, few studies have examined lowering dietary n-6 PUFA. This review will evaluate the effect of lowering dietary n-6 PUFA on levels and metabolism of ARA and DHA in animal models and in humans, with a primary focus on the brain. RECENT FINDINGS: In animal models, lowering dietary ARA or linoleic acid generally lowers levels of brain ARA and raises DHA. Lowering dietary n-6 PUFA can also modulate the levels of ARA and DHA metabolizing enzymes, as well as their associated bioactive mediators. Human studies examining changes in plasma fatty acid composition following n-6 PUFA lowering demonstrate no changes in levels of ARA and DHA, though there is evidence of alterations in their respective bioactive mediators. SUMMARY: Lowering dietary n-6 PUFA, in animal models, can alter the levels and metabolism of ARA and DHA in the brain, but it remains to be determined whether these changes are clinically meaningful.
Authors: Ameer Y Taha; Marie Hennebelle; Jun Yang; Daisy Zamora; Stanley I Rapoport; Bruce D Hammock; Christopher E Ramsden Journal: Prostaglandins Leukot Essent Fatty Acids Date: 2016-05-11 Impact factor: 4.006
Authors: Parco Chan; Ivonne Suridjan; Dana Mohammad; Nathan Herrmann; Graham Mazereeuw; Lyn M Hillyer; David W L Ma; Paul I Oh; Krista L Lanctôt Journal: J Am Heart Assoc Date: 2018-05-05 Impact factor: 5.501
Authors: Markus Herrmann; Sebastian Simstich; Günter Fauler; Edith Hofer; Eva Fritz-Petrin; Wolfgang Herrmann; Reinhold Schmidt Journal: Aging (Albany NY) Date: 2021-09-23 Impact factor: 5.682